GL1X · GenesisL1 explorer

Research workbench

Human iduronidase apo structure P21 form

Analyse Human iduronidase apo structure P21 form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MJ4
Type
protein
Length
603 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-L-iduronidase
EC
3.2.1.76
UniProt
P35475
Ligands
NAG, MAN, BMA, CL
Pockets
7 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-L-iduronidase (EC 3.2.1.76)protein60325% helix, 31% strandP35475

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 2 copies
  • BMA · beta-D-mannopyranose · sugar · chains A
  • CL · Chloride ion · ion · chains A
  • GOL · Glycerol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1750.700.9527empty
21580.600.8320empty
31690.520.8037GOL
41270.470.7820GOL
51170.400.7518empty

Modifications

Observed in the structure: 3 glycan (N-glycosylation).

Compared structures

  • 4MJ4 · Human iduronidase apo structure P21 form · the same entry in another collection · chain A against A, TM-score 1.00
  • P35475 · AlphaFold monomer V2.0 prediction for alpha-L-iduronidase (P35475) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.